USPTO Seeks Comments on Updating Patent Secrecy and Export License Forms
Published Date: 11/19/2025
Notice
Summary
The USPTO is asking for public feedback on updating the forms and rules about keeping some patent info secret and controlling patent exports to protect national security. This affects inventors and companies who want to file patents abroad or deal with sensitive tech. Comments are open until January 20, 2026, and the update aims to keep the process smooth without extra costs.
Analyzed Economic Effects
4 provisions identified: 0 benefits, 4 costs, 0 mixed.
Secrecy orders can withhold patents for national security
If an interested Government agency finds disclosure harmful to national security, the USPTO can place a secrecy order that withholds publication and the grant of a patent. A secrecy order remains in effect for one year from its date and may be renewed in one‑year increments; international applications under a secrecy order will not be forwarded to the International Bureau while the order is in effect.
Annual paperwork time and cost burdens
The USPTO estimates this collection will involve 7,318 respondents and 7,318 responses annually, totaling 4,207 respondent hours and an estimated $1,880,529 in hourly cost burden each year. The agency also estimates $1,622,976 in yearly non-hour costs (filing fees and postage). Comments on this collection are due January 20, 2026.
Per-petition filing fees for export/secrecy petitions
The rule lists specific filing fees for petitions: many expedited license petitions cost $235 for undiscounted entities, $94 for small entities, and $47 for micro entities. For example, 6,342 expedited no‑corresponding‑application petitions are priced at $235 each, producing a large part of the $1,622,158 total estimated annual non‑hour cost burden.
Foreign filing license and retroactive license process
Filing a U.S. patent application is treated as a request for a foreign filing license, but applicants may petition for a foreign filing license before a U.S. filing, request a change in license scope, or seek a retroactive license if an application was filed abroad without the proper license. These petitions are included in the information collection and may require the time and fees described.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16744, Request for Comments on Community Outreach Office Locations in the Southwest States
The USPTO wants your ideas on where to open new community outreach offices in the Southwest states like Arizona and Texas. These offices will help inventors, small businesses, and students get better support with patents. Share your thoughts by September 16, 2026, so the USPTO can pick the best spots and keep innovation booming without extra costs to you!
2026-16315, Administrative Updates to the General Requirements Bulletin for Admission to the Examination for Registration To Practice in Patent Cases Before the United States Patent and Trademark Office
Starting August 11, 2026, the USPTO is upgrading Biomedical Science degrees from Category B to Category A for patent bar eligibility. This means more people with this degree can now take the patent exam and become patent practitioners. No extra fees or delays—just a smoother path for those with the right science background to join the patent world!
2026-14941, Grant of Interim Extension of the Term of U.S. Patent No. 8,461,196; Centanafadine Hydrochloride
Otsuka America Pharmaceutical got a one-year extra patent life for their drug centanafadine hydrochloride because the FDA review is still going on. This means they keep exclusive rights to the drug until July 25, 2027, giving them more time to sell it without competition. This extension helps the company protect their investment while the drug gets final approval.
2026-14939, Grant of Interim Extension of the Term of U.S. Patent No. 8,877,798; Centanafadine Hydrochloride
Otsuka America Pharmaceutical got a one-year extra patent life for their drug centanafadine hydrochloride because the FDA review is still going on. This means their patent, which was set to expire on July 25, 2026, now lasts until July 25, 2027. This extension helps Otsuka keep exclusive rights to their drug a bit longer while waiting for final FDA approval.
2026-14793, Requirement To Identify All Real Parties in Interest to a Third Party Request for an Ex Parte Reexamination
The USPTO wants anyone asking for a third-party ex parte reexamination to clearly say who’s really behind the request. This helps stop sneaky tricks and keeps the process honest. If you’re involved, get ready to share this info confidentially by August 21, 2026, or risk delays or issues.
2026-14388, Agency Information Collection Activities; Submission to the Office of Management and Budget for Review and Approval; Comment Request; Admission to Practice and Roster of Registered Patent Attorneys and Agents Admitted to Practice Before the United States Patent and Trademark Office
The USPTO is asking for public feedback on its paperwork rules for patent attorneys and agents who want to practice before the office. This helps keep the process smooth and fair without making people fill out too many forms. If you have thoughts, send them in by August 17, 2026—no fees or big changes are happening right now, just a review.
Previous / Next Documents
Previous: 2025-20245, Product Change-Priority Mail Express, Priority Mail, and USPS Ground Advantage Negotiated Service Agreements; Priority Mail and USPS Ground Advantage Negotiated Service Agreements; Priority Mail Negotiated Service Agreements
The Postal Service is updating its shipping deals by adding new contracts for Priority Mail Express, Priority Mail, and USPS Ground Advantage. These changes affect businesses using these services and could mean new pricing or options starting soon. The updates were officially filed in November 2025 and aim to keep shipping smooth and competitive.
Next: 2025-20248, Agency Information Collection Activities; Submission for OMB Review; Comment Request; Weekly Claims and Extended Benefits Data and Weekly Initial and Continued Weeks Claimed
The Department of Labor is updating how states report weekly unemployment claims and extended benefits data to improve accuracy and timing. These changes help decide when extra unemployment benefits start or stop, affecting states and job seekers. Comments on this update are open until December 19, 2025, with no new costs expected.